H-Index
34
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
call: +1.631.629.4327
Mon-Fri 10 am - 2 pm EST

Logo

MSMbanner
Medical Science Monitor Basic Research

AmJCaseRep
MedSciTechnol

eISSN: 2329-0358

Get your full text copy in PDF

Donor-Specific Antibodies and Kidney Transplant Rejection

A Slavcev

Ann Transplant 2003; 8(3): 12-15

ID: 7521


The role played by non-complement binding antibodies after kidney transplantation is still not satisfactorily elucidated. A growing number of publications suggest that the detection of antibodies to donor HLA antigens by more sensitive methods than the standard complement-dependent cytotoxicity test is often associated with acute and chronic immunological complications and generally worse graft prognosis. In this review, we briefly discuss several recent reports on the clinical significance of non-cytotoxic anti-HLA antibodies, which might have important implications for patient immunosuppression and management after organ transplantation.

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree